• Disc Medicine CEO John D. Quisel cut his stake to 226,064 shares in transactions dated July 13.
• Sold 32,? Wait: disposed of 33,000 shares at weighted-average prices of USD 74.27, USD 74.95, USD 76.05.
• Exercised options for 33,000 shares at USD 9.86 and USD 13.5 before the sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-303535), on July 14, 2026, and is solely responsible for the information contained therein.